Antioxidants in Kidney Diseases: The Impact of Bardoxolone Methyl

Drugs targeting the renin-angiotensin-aldosterone system (RAAS) are the mainstay of therapy to retard the progression of proteinuric chronic kidney disease (CKD) such as diabetic nephropathy. However, diabetic nephropathy is still the first cause of end-stage renal disease. New drugs targeted to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas-Rivera, Jorge, Ortiz, Alberto, Egido, Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373077/
https://www.ncbi.nlm.nih.gov/pubmed/22701794
http://dx.doi.org/10.1155/2012/321714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373077/
https://www.ncbi.nlm.nih.gov/pubmed/22701794
http://dx.doi.org/10.1155/2012/321714

Ejemplares similares